Trial Profile
A retrospective study of capecitabine or capecitabine and oxaliplatin as an adjuvant chemotherapy in elderly patients with stage III colon cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- 06 Oct 2015 New trial record